Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 3, 2003, Pages 434-439

  Keaney Jr , John F ^a   Larson, Martin G ^c   Vasan, Ramachandran S ^a,c   Wilson, Peter W F ^a,c   Lipinska, Izabella ^a   Corey, Diane ^c   Massaro, Joseph M ^b,c   Sutherland, Patrice ^c   Vita, Joseph A ^a   Benjamin, Emelia J ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c Blood Inst's F   (United States)

Author keywords

Cardiovascular disease; Diabetes; Isoprostanes; Obesity; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; COMORBIDITY; DIABETES MELLITUS; DINOPROST; F2-ISOPROSTANES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; OXIDATIVE STRESS; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 0037342568     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000058402.34138.11     Document Type: Article

References (41)

1. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
2. Gopaul NK, Änggård EE, Mallet Al, Betteridge DJ, Wolff SP, Nourooz-Zadeh J. Plasma 8-epi-PGF2alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 1995;368:225-229.
3. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
4. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
5. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 1990;87:9383-9387.
6. Roberts LJ, Morrow ID. The generation and actions of isoprostanes. Biochim Biophys Acta. 1997;1345:121-135.
7. (2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem. 1999;272:209-215.
8. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham offspring study. Am J Epidemiol. 1979;110:281-290.
9. The Framingham Study. In: Kannel WB, Wolf PA, Garrison RJ, eds. An Epidemiological Investigation of Cardiovascular Disease, Section 34. (NIH) 87-2703. Bethesda, MD: National Heart, Lung, and Blood Institute; 1987.
10. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute, Inc.; 1999.
11. Laursen JB, Rajagopalan S, Galis ZS, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:588-593.
12. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:2546-2551.
13. Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Biochem J. 1991;277:133-138.
14. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA. 1989;86:6377-6381.
15. Pilz H, Oguogho A, Chehne F, Lupattelli G, Palumbo B, Sinzinger H. Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). Thromb Res. 2000;99:209-221.
16. [Increased plasma level of lipid peroxidation products (F2-isoprostanes) in smokers]. Dtsch Med Wochenschr. 1995;120:1107.
17. 2α after restarting smoking. Prostaglandins Leukot Essent Fatty Acids. 2001;64:307-310.
18. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Mccarthy S, Betteridge DJ, Wolff SP. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes. 1995;44:1054-1058.
19. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control. Circulation. 1999;99:224-229.
20. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA. 1993;90:6434-6438.
21. Baynes JW. Role of oxidative stress in the development of complications in diabetes. Diabetes. 1991;40:405-412.
22. Heinecke JW, Baker L, Rosen H, Chait A. Superoxide mediated modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest. 1986;77:757-761.
23. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49:1939-1945.
24. Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, Packer L. Factors associated with oxidative stress in human populations. Am J Epidemiol. 2002;156:274-285.
25. Dietrich M, Block G, Hudes M, Morrow JD, Norkus EP, Traber MG, Cross CE, Packer L. Antioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev. 2002;11:7-13.
26. Trevisan M, Browne R, Ram M, Muti P, Freudenheim J, Carosella AM, Armstrong D. Correlates of markers of oxidative status in the general population. Am J Epidemiol. 2001;154:348-356.
27. Baron AD. Impaired glucose tolerance as a disease. Am J Cardiol. 2001;88:16H-19H.
28. Facchini FS, Hua NW, Reaven GM, Stoohs RA. Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? Free Radic Biol Med. 2000;29:1302-1306.
29. Rudich A, Kozlovsky N, Potashnik R, Bashan N. Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am J Physiol. 1997;272: E935-E940.
30. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes. 1998;47:1562-1569.
31. 2 in tumor necrosis factor alpha-mediated insulin resistance. J Biol Chem. 1999;274:25078-25084.
32. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest. 1992;89:1006-1013.
33. 2-isoprostanes in human urine. Proc Natl Acad Sci USA. 1999;96:13381-13386.
34. 2α. Prostaglandins Leukot Essent Fatty Acids. 2000;62:209-216.
35. Cracowski JL, Ploin D, Bessard J, Baguet JP, Stanke-Labesque F, Mallion JM, Bost M, Bessard G. Formation of isoprostanes in children with type IIa hypercholesterolemia. J Cardiovasc Pharmacol. 2001;38:228-231.
36. 2 isoprostanes in hypercholesterolemia. Circulation. 1998;98:2822-2828.
37. Kannel WB. Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol. 1995;76:69C-77C.
38. Reckelhoff JF, Zhang H, Srivastava K, Roberts LJ, Morrow JD, Romero JC. Subpressor doses of angiotensin II increase plasma F(2)-isoprostanes in rats. Hypertension. 2000;35:476-479.
39. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation. 2000;101:1722-1728.
40. Hensley K, Floyd RA. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys. 2002;397:377-383.
41. Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M, Tamai H, Takeshita A. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol. 2002;22:438-442.